KR100378949B1 - 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체 - Google Patents
세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체 Download PDFInfo
- Publication number
- KR100378949B1 KR100378949B1 KR10-2000-0025665A KR20000025665A KR100378949B1 KR 100378949 B1 KR100378949 B1 KR 100378949B1 KR 20000025665 A KR20000025665 A KR 20000025665A KR 100378949 B1 KR100378949 B1 KR 100378949B1
- Authority
- KR
- South Korea
- Prior art keywords
- cell adhesion
- βig
- activity
- cell
- domain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4718—Cytokine-induced proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Abstract
Description
Claims (8)
- 삭제
- 삭제
- 보존적 서열로서 아스파르트산-아이소류우신을 포함하며서열번호 2로 기재되는 NKDIL 아미노산 서열을 포함하는 것을 특징으로 하는 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및 그의 유도체.
- 보존적 서열로서 아스파르트산-아이소류우신을 포함하며서열번호 3으로 기재되는 EPDIM 아미노산 서열을 포함하는 것을 특징으로 하는 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및 그의 유도체.
- 제 3항 또는 제 4항에 있어서, α3β1 인테그린을 통하여 세포 부착 및 확산 활성을 매개하는 것을 특징으로 하는 펩타이드 및 그의 유도체.
- 제 3항 또는 제 4항에 있어서, βig-h3, 피브로넥틴(fibronectin) 또는 라미닌(laminin)의 세포 부착 활성에 대한 세포 탈착 효과를 나타내는 것을 특징으로 하는 펩타이드 및 그의 유도체.
- 제 3항 또는 제 4항의 펩타이드 및 그의 유도체를 유효성분으로 함유하는 것을 특징으로 하는 창상치유, 조직재생 또는 암전이 억제용 약학적 조성물.
- 삭제
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0025665A KR100378949B1 (ko) | 2000-05-13 | 2000-05-13 | 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체 |
AU2001220262A AU2001220262B2 (en) | 2000-05-13 | 2000-12-06 | Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
US10/276,601 US7070956B2 (en) | 2000-05-13 | 2000-12-06 | Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
RU2002133450/13A RU2241005C2 (ru) | 2000-05-13 | 2000-12-06 | Олигопептид, обладающий активностью в прикреплении, распластывании и откреплении клеток, и фармацевтическая композиция |
AU2026201A AU2026201A (en) | 2000-05-13 | 2000-12-06 | Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
EP00983515A EP1282638A4 (en) | 2000-05-13 | 2000-12-06 | PEPTIDES AND DERIVATIVES HAVING CELL BINDING, SPREADING AND ABLATION ACTIVITY |
CNB008195293A CN1221565C (zh) | 2000-05-13 | 2000-12-06 | 显示细胞附着,铺展和脱附活性的肽和它们的衍生物 |
CA002409546A CA2409546C (en) | 2000-05-13 | 2000-12-06 | Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
IL15240900A IL152409A0 (en) | 2000-05-13 | 2000-12-06 | Peptides and derivatives thereof showing cell attachtment, spreading and detachment activity |
JP2001585147A JP3755649B2 (ja) | 2000-05-13 | 2000-12-06 | 細胞接着、伸張、および剥離活性を示すペプチドおよびその誘導体 |
PCT/KR2000/001413 WO2001087928A1 (en) | 2000-05-13 | 2000-12-06 | Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
IL152409A IL152409A (en) | 2000-05-13 | 2002-10-22 | Peptides and their derivatives showing cell linkages and dispersal and dissociation activity |
US11/307,490 US7250400B2 (en) | 2000-05-13 | 2006-02-09 | Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
US11/777,245 US20080015150A1 (en) | 2000-05-13 | 2007-07-12 | Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0025665A KR100378949B1 (ko) | 2000-05-13 | 2000-05-13 | 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010104178A KR20010104178A (ko) | 2001-11-24 |
KR100378949B1 true KR100378949B1 (ko) | 2003-04-08 |
Family
ID=36584803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0025665A KR100378949B1 (ko) | 2000-05-13 | 2000-05-13 | 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체 |
Country Status (10)
Country | Link |
---|---|
US (3) | US7070956B2 (ko) |
EP (1) | EP1282638A4 (ko) |
JP (1) | JP3755649B2 (ko) |
KR (1) | KR100378949B1 (ko) |
CN (1) | CN1221565C (ko) |
AU (2) | AU2026201A (ko) |
CA (1) | CA2409546C (ko) |
IL (2) | IL152409A0 (ko) |
RU (1) | RU2241005C2 (ko) |
WO (1) | WO2001087928A1 (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100385293B1 (ko) * | 2000-05-13 | 2003-05-23 | 주식회사 리젠 바이오텍 | βig-h3의 일부 도메인을 이용한 세포 부착 및 창상치유 방법 |
KR100378949B1 (ko) * | 2000-05-13 | 2003-04-08 | 주식회사 리젠 바이오텍 | 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체 |
KR100885071B1 (ko) * | 2002-05-14 | 2009-02-25 | 재단법인서울대학교산학협력재단 | 세포에 부착하는 올리고펩타이드 |
AU2003251646A1 (en) * | 2002-07-26 | 2004-02-23 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Use of tgf beta ig-h3 for preventing and treating obesity, diabetes and/or metabolic syndrome |
KR100481796B1 (ko) * | 2002-10-02 | 2005-04-11 | 경북대학교 산학협력단 | 섬유아세포의 αvβ5 인테그린과 특이적으로 결합하는βig-h3 단백질 유래 펩타이드 |
WO2005099743A1 (en) * | 2004-04-13 | 2005-10-27 | Kyungpook National University Industry-Academic Cooperation Foundation | Novel use of a polypeptide comprising fas-1 domain |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5444164A (en) * | 1992-02-05 | 1995-08-22 | Bristol-Myers Squibb Company | TGF-β induced gene |
US5952223A (en) * | 1996-03-22 | 1999-09-14 | Millennium Pharmaceuticals | Compositions for the diagnosis and treatment of Chediak-Higashi syndrome |
AU2001233114A1 (en) * | 2000-02-04 | 2001-08-14 | Aeomica, Inc. | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
KR100385293B1 (ko) * | 2000-05-13 | 2003-05-23 | 주식회사 리젠 바이오텍 | βig-h3의 일부 도메인을 이용한 세포 부착 및 창상치유 방법 |
KR100378949B1 (ko) * | 2000-05-13 | 2003-04-08 | 주식회사 리젠 바이오텍 | 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체 |
US20030211141A1 (en) * | 2001-12-11 | 2003-11-13 | Lebaron Richard G. | Genetic and protein manipulation of betaIG-H3 for the treatment and cure of muscular dystrophies |
-
2000
- 2000-05-13 KR KR10-2000-0025665A patent/KR100378949B1/ko active IP Right Grant
- 2000-12-06 US US10/276,601 patent/US7070956B2/en not_active Expired - Fee Related
- 2000-12-06 CA CA002409546A patent/CA2409546C/en not_active Expired - Fee Related
- 2000-12-06 WO PCT/KR2000/001413 patent/WO2001087928A1/en active IP Right Grant
- 2000-12-06 EP EP00983515A patent/EP1282638A4/en not_active Withdrawn
- 2000-12-06 CN CNB008195293A patent/CN1221565C/zh not_active Expired - Fee Related
- 2000-12-06 RU RU2002133450/13A patent/RU2241005C2/ru not_active IP Right Cessation
- 2000-12-06 IL IL15240900A patent/IL152409A0/xx active IP Right Grant
- 2000-12-06 AU AU2026201A patent/AU2026201A/xx not_active Withdrawn
- 2000-12-06 AU AU2001220262A patent/AU2001220262B2/en not_active Ceased
- 2000-12-06 JP JP2001585147A patent/JP3755649B2/ja not_active Expired - Fee Related
-
2002
- 2002-10-22 IL IL152409A patent/IL152409A/en not_active IP Right Cessation
-
2006
- 2006-02-09 US US11/307,490 patent/US7250400B2/en not_active Expired - Fee Related
-
2007
- 2007-07-12 US US11/777,245 patent/US20080015150A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP3755649B2 (ja) | 2006-03-15 |
AU2001220262B2 (en) | 2005-08-18 |
AU2026201A (en) | 2001-11-26 |
IL152409A (en) | 2007-12-03 |
RU2241005C2 (ru) | 2004-11-27 |
EP1282638A1 (en) | 2003-02-12 |
EP1282638A4 (en) | 2004-08-11 |
CA2409546C (en) | 2009-09-08 |
US7070956B2 (en) | 2006-07-04 |
US20060128631A1 (en) | 2006-06-15 |
US7250400B2 (en) | 2007-07-31 |
IL152409A0 (en) | 2003-05-29 |
CN1457340A (zh) | 2003-11-19 |
WO2001087928A1 (en) | 2001-11-22 |
US20080015150A1 (en) | 2008-01-17 |
JP2004511427A (ja) | 2004-04-15 |
CA2409546A1 (en) | 2001-11-22 |
CN1221565C (zh) | 2005-10-05 |
US20030175885A1 (en) | 2003-09-18 |
KR20010104178A (ko) | 2001-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lucas et al. | Mapping the lectin-like activity of tumor necrosis factor | |
US5849701A (en) | Peptide inhibitors of fibronectin and related collagen-binding proteins | |
US8603967B2 (en) | Carrier peptide fragment and use thereof | |
Morbidelli et al. | Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin | |
EP3228626B1 (en) | Peptide having activity to improve skin condition and use thereof | |
JP2000506523A (ja) | 血管形成の阻害剤として有用なトロポニンのサブユニットおよびフラグメント | |
Su et al. | Bruton's tyrosine kinase (BTK) is a binding partner for hypoxia induced mitogenic factor (HIMF/FIZZ1) and mediates myeloid cell chemotaxis | |
US7250400B2 (en) | Peptides and derivatives thereof showing cell attachment, spreading and detachment activity | |
Galán et al. | Inhibition of lung tumor colonization and cell migration with the disintegrin crotatroxin 2 isolated from the venom of Crotalus atrox | |
US20100331253A9 (en) | Method for cell adhesion and wound healing | |
JP2010508845A (ja) | ヘパリン結合配列に融合した増殖因子を使用して心臓修復を促進する方法 | |
WO2000067771A1 (en) | Antiangiogenic endostatin peptides, endostatin variants and methods of use | |
CN114605501B (zh) | 一种可拮抗fus蛋白rna结合活性的多肽fip-21及其应用 | |
AU2001220262A1 (en) | Peptides and derivatives thereof showing cell attachment, spreading and detachment activity | |
KR100335348B1 (ko) | 종양 혈관신생 억제기능을 가지는 살모신을 유효성분으로 함유하는 항암제 | |
US7517654B2 (en) | Peptide and a derivative thereof promoting cell adhesion and spreading | |
KR100568755B1 (ko) | Yh 모티프를 포함하는 펩타이드를 유효성분으로함유하는 혈관신생 억제제 | |
Madden et al. | A peptide derived from neutrophil inhibitory factor (NIF) blocks neutrophil adherence to endothelial cells | |
Wei et al. | Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity | |
KR100481796B1 (ko) | 섬유아세포의 αvβ5 인테그린과 특이적으로 결합하는βig-h3 단백질 유래 펩타이드 | |
KR101813629B1 (ko) | 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도 | |
KR20080002213A (ko) | 암세포의 성장 및 전이 억제 활성을 갖는 폴리펩타이드또는 그의 융합 단백질 | |
KR100481206B1 (ko) | 신규한 신생혈관생성 저해제 | |
KR20150138721A (ko) | 켈로이드 억제용 조성물 및 그 억제 방법 | |
Xianrong et al. | Expression, purification of a synthetic fuse-protein-TSF from PF4 and TSP1 fragments and its effect on angiogenesis and tumor growth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130326 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20140324 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160325 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20170327 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20180305 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20190207 Year of fee payment: 17 |
|
FPAY | Annual fee payment |
Payment date: 20200311 Year of fee payment: 18 |